top of page

Topic

Hepatology

23 Podcasts • 4 Courses on BackTable

Hear how experienced clinicians in Hepatology approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Tumor Board

Episode # 59  •  12 May 2026

Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?

With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most likely to shape HCC care? In this final episode of the BackTable 2026 HCC Creator Weekend™, Drs. Lingling Du, A. Craig Lockhart, and Jon Mizrahi focus on the future of hepatocellular carcinoma beyond established PD-1/CTLA-4 regimens.

More on Hepatology

Loading recent podcasts…

Tumor Board

Tumor Board Episode #59

May 12, 2026

with Dr. Jonathan Mizrahi, Dr. Lingling Du, Dr. Craig Lockhart

Evolving Treatment Paradigms in Hepatocellular Carcinoma: What's on the Horizon?

With new systemic and liver-directed approaches under investigation, which targets and treatment strategies are most...

100+ listens

VI

VI Episode #642

May 7, 2026

with Dr. Beau Toskich, Dr. Zach Berman, Dr. Venkatesh Krishnasamy

Exploring CPN & Radiation Segmentectomy in Liver Cancer

Complete pathologic necrosis (CPN) rates above 90%? This week’s BackTable episode from the 2026 HCC Creator Weekend™ is...

30+ listens

VI

VI Episode #641

May 5, 2026

with Dr. Neil Mehta, Dr. Riad Salem, Dr. Tyler Sandow

Understanding BCLC Updates & Guidelines

With recent updates to the Barcelona Clinic Liver Classification (BCLC), how should multidisciplinary teams adapt their...

1,500+ listens

VI

VI Episode #592

Nov 25, 2025

with Dr. Jason Hoffmann, Dr. Sabeen Dhand

Comparing Thermal Ablation Techniques for Liver Lesions

With the range of interventional modalities that are available for metastatic liver tumors, when should you advocate...

1,700+ listens

VI

VI Episode #644

May 12, 2026

with Dr. Neil Mehta, Dr. Ari Cohen, Dr. Venkatesh Krishnasamy

Optimizing Liver Transplant Pathways & Decision-Making

A high-functioning HCC tumor board can turn complex transplant decisions into coordinated treatment plans that account...

780+ listens

Tumor Board

Tumor Board Episode #58

May 5, 2026

with Dr. Craig Lockhart, Dr. Lingling Du, Dr. Jonathan Mizrahi

Advanced Hepatocellular Carcinoma: Navigating Second-Line Therapy Options

When first-line treatment for advanced hepatocellular carcinoma (HCC) fails and the disease progresses, what options...

100+ listens

Tumor Board

Tumor Board Episode #57

Apr 28, 2026

with Dr. Lingling Du, Dr. Craig Lockhart, Dr. Jonathan Mizrahi

First-Line Therapy for Advanced Hepatocellular Carcinoma: Decisions in the Real World

Learn how a “watershed” clinical trial in 2020 completely overturned a decade of standard care for liver cancer. In...

150+ listens

VI

VI Episode #580

Oct 10, 2025

with Dr. Vijay Ramalingam, Dr. Christopher Beck

How to Manage Portal Vein Thrombosis

When a patient presents with portal vein thrombosis (PVT), how do you decide between anticoagulation, intervention, and...

3,900+ listens

BRTO & Portal Vein Recanalization

VI Course

1.5 hours, 33 lessons

TIPS Tools & Advanced Techniques

VI Course

1.5 hours, 29 lessons

SuperCourse: Portal Interventions

VI Course

5 hours, 91 lessons

IR, Surgical & Transplant Collaboration for HCC

Tumor Board Course

2 hours, 22 lessons

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page